JP5957450B2 - 生物学的流体中の、中間体及びタンパク質結合尿毒症毒素の含有量を決定するための方法及び装置 - Google Patents

生物学的流体中の、中間体及びタンパク質結合尿毒症毒素の含有量を決定するための方法及び装置 Download PDF

Info

Publication number
JP5957450B2
JP5957450B2 JP2013517023A JP2013517023A JP5957450B2 JP 5957450 B2 JP5957450 B2 JP 5957450B2 JP 2013517023 A JP2013517023 A JP 2013517023A JP 2013517023 A JP2013517023 A JP 2013517023A JP 5957450 B2 JP5957450 B2 JP 5957450B2
Authority
JP
Japan
Prior art keywords
concentration
sample
wavelength range
fluorescence
dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013517023A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013534630A (ja
JP2013534630A5 (enExample
Inventor
フリドリン,イヴォ
ウーリン,フレドリック
イエロトスカヤ,ジャナ
タンネール,リスト
アルンド,ユルゲン
Original Assignee
オプトフルイド テクノロジーズ オーユー
オプトフルイド テクノロジーズ オーユー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EEP201000056A external-priority patent/EE05676B1/xx
Priority claimed from EEP201000085A external-priority patent/EE05669B1/xx
Application filed by オプトフルイド テクノロジーズ オーユー, オプトフルイド テクノロジーズ オーユー filed Critical オプトフルイド テクノロジーズ オーユー
Publication of JP2013534630A publication Critical patent/JP2013534630A/ja
Publication of JP2013534630A5 publication Critical patent/JP2013534630A5/ja
Application granted granted Critical
Publication of JP5957450B2 publication Critical patent/JP5957450B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • External Artificial Organs (AREA)
JP2013517023A 2010-06-28 2011-06-28 生物学的流体中の、中間体及びタンパク質結合尿毒症毒素の含有量を決定するための方法及び装置 Active JP5957450B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EEP201000056A EE05676B1 (et) 2010-06-28 2010-06-28 Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide m„„ramiseks bioloogilistes vedelikes
EEP201000056 2010-06-28
EEP201000085 2010-12-10
EEP201000085A EE05669B1 (et) 2010-12-10 2010-12-10 Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide m„„ramiseks bioloogilistes vedelikes
PCT/EE2011/000008 WO2012000521A1 (en) 2010-06-28 2011-06-28 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid

Publications (3)

Publication Number Publication Date
JP2013534630A JP2013534630A (ja) 2013-09-05
JP2013534630A5 JP2013534630A5 (enExample) 2014-08-07
JP5957450B2 true JP5957450B2 (ja) 2016-07-27

Family

ID=44508544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517023A Active JP5957450B2 (ja) 2010-06-28 2011-06-28 生物学的流体中の、中間体及びタンパク質結合尿毒症毒素の含有量を決定するための方法及び装置

Country Status (10)

Country Link
US (1) US9103789B2 (enExample)
EP (1) EP2585830B1 (enExample)
JP (1) JP5957450B2 (enExample)
KR (1) KR101848527B1 (enExample)
CN (1) CN102985822A (enExample)
AU (1) AU2011274009B2 (enExample)
BR (1) BR112012033625A2 (enExample)
CA (1) CA2837488C (enExample)
NZ (1) NZ605685A (enExample)
WO (1) WO2012000521A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012112790A1 (de) * 2012-12-20 2014-06-26 B. Braun Avitum Ag Verfahren und Vorrichtung zur Bestimmung von Abfallprodukten wie Indoxyl Sulfate in der Dialyse
US10150983B2 (en) * 2013-02-19 2018-12-11 Nipro Corporation Method for measuring indoxyl sulfuric acid
CN104991026A (zh) * 2015-06-29 2015-10-21 苏州东辰林达检测技术有限公司 尿液中甲基马尿酸的检测方法
EP3537135A1 (en) * 2018-03-05 2019-09-11 Tallinn University of Technology A device and method for assessment of a concentration of free pentosidine in a spent dialysate
JP7207702B2 (ja) * 2018-11-06 2023-01-18 国立研究開発法人農業・食品産業技術総合研究機構 成分抽出方法、蛍光指紋測定装置、及びコンピュータが実行可能なプログラム
GB202104698D0 (en) * 2021-03-31 2021-05-12 Tallinn Univ Of Technology Multiparametric optical method and apparatus for the determination of uremic solutes, including uremic toxins, in biological fluids
TWI838830B (zh) * 2022-04-08 2024-04-11 財團法人工業技術研究院 β2-微球蛋白濃度的分析方法及裝置
CN120948421A (zh) * 2025-10-15 2025-11-14 天津医科大学 一种定量-判别一体化尿毒症智能检测系统

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3261264B2 (ja) 1994-07-13 2002-02-25 株式会社堀場製作所 多成分水溶液の分析方法およびその分析装置
WO1998019592A1 (en) * 1996-11-01 1998-05-14 Rio Grande Medical Technologies, Inc. Dialysis monitoring method and apparatus
US6261848B1 (en) * 1998-05-08 2001-07-17 The Johns Hopkins University Miniature immuno-optical rapid analyte sensor platform
SE525639C2 (sv) 1998-06-04 2005-03-22 Thore Falkvall Bestämning av slaggprodukter i dialysvätska med hjälp av optisk sensor
AUPR748501A0 (en) * 2001-09-04 2001-09-27 Life Therapeutics Limited Renal dialysis
US8337444B2 (en) * 2001-05-22 2012-12-25 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis
RU2212029C1 (ru) 2001-12-03 2003-09-10 Общество с ограниченной ответственностью "Клиника экстракорпоральной гемокоррекции" Способ анализа жидкой биологической среды в процессе мониторинга
US7002670B2 (en) * 2002-06-12 2006-02-21 Baxter International Inc. Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance
EP1643240A4 (en) * 2003-07-03 2010-09-22 Wako Pure Chem Ind Ltd METHOD FOR MEASURING CERTAIN COMPONENTS BY MEANS OF SPECTRAL MEASUREMENT
US7427508B2 (en) 2003-10-09 2008-09-23 Organotek Defense System Corporation Method for assaying multi-component mixtures
WO2005069737A2 (en) * 2004-01-27 2005-08-04 Ramot At Tel Aviv University Ltd. Method and system for detecting analytes
EP1751523B1 (en) 2004-05-13 2017-10-04 NarTest AS A portable device and method for on-site detection and quantification of drugs
US7966051B2 (en) * 2005-01-11 2011-06-21 Olympus Corporation Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten
WO2009071102A1 (en) 2007-12-04 2009-06-11 Tallinn University Of Technology Optical method and device for measuring concentrations of substances in biological fluids

Also Published As

Publication number Publication date
AU2011274009B2 (en) 2016-06-23
WO2012000521A1 (en) 2012-01-05
EP2585830A1 (en) 2013-05-01
EP2585830B1 (en) 2018-04-25
US20130193347A1 (en) 2013-08-01
CA2837488A1 (en) 2012-01-05
CN102985822A (zh) 2013-03-20
BR112012033625A2 (pt) 2016-10-25
JP2013534630A (ja) 2013-09-05
US9103789B2 (en) 2015-08-11
KR101848527B1 (ko) 2018-04-12
NZ605685A (en) 2014-10-31
AU2011274009A1 (en) 2013-01-31
KR20130038347A (ko) 2013-04-17
CA2837488C (en) 2021-10-26

Similar Documents

Publication Publication Date Title
JP5957450B2 (ja) 生物学的流体中の、中間体及びタンパク質結合尿毒症毒素の含有量を決定するための方法及び装置
Lesaffer et al. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane
CN103228301B (zh) 用于体外血液处理的装置
Galli et al. Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers
Dumont et al. Supplementation with a low dose of l‐arginine reduces blood pressure and endothelin‐1 production in hypertensive uraemic rats
EP2577270A1 (en) Method and device for measuring and monitoring concentration of substances in a biological fluid
Delfino et al. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients
JP2014518517A (ja) 患者の治療、好ましくは血液透析、血液透析濾過、および腹膜透析の少なくとも1つを監視する方法および装置
Chen et al. High homocysteine, low vitamin B-6, and increased oxidative stress are independently associated with the risk of chronic kidney disease
US20240102930A1 (en) Multiparametric Optical Method and Device for determining Uremic Solutes, including Uremix Toxins, in Biological Fluids
Park et al. Inhalation exposure to cigarette smoke induces endothelial nitric oxide synthase uncoupling and enhances vascular collagen deposition in streptozotocin-induced diabetic rats
Holmar et al. Estimation of removed uremic toxin indoxyl sulphate during hemodialysis by using optical data of the spent dialysate
Bonomini et al. Removal of uraemic plasma factor (s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells
Mozar et al. Uremic toxin indoxyl sulfate inhibits human vascular smooth muscle cell proliferation
Stange et al. Industrial stabilizers caprylate and N‐acetyltryptophanate reduce the efficacy of albumin in liver patients
Kannampuzha et al. Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis
Holmar et al. Quantification of indoxyl sulphate in the spent dialysate using fluorescence spectra
Brandl et al. Spectroscopic hemoglobin and bilirubin measurement on optically opaque particulate fluids
Atanya The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy
Holmar et al. New optical method for estimation of protein bound uremic toxins elimination
Begovic et al. Seasonal variations in nutritional status and oxidative stress in patients on hemodialysis: Are they related?
Tankiewicz et al. Anthranilic acid–uraemic toxin damaged red cell’s membrane
Jerotskaja et al. A multicenter study of removed uric acid estimated by ultra violet absorbance in the spent dialysate
Lauri et al. Optical dialysis adequacy sensor: contribution of chromophores to the ultra violet absorbance in the spent dialysate
Garcia Chiarello et al. Hyperhomocysteinemia and oxidative stress during dialysis treatment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140620

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151006

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160518

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160607

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160620

R150 Certificate of patent or registration of utility model

Ref document number: 5957450

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250